Funding Rounds
Enterome Series B (2014, $12M)
EnteromeCutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.
Summary
Stage: Series B
Raised Amount: $12.00M
Raised Date: 2014-01-01
Stage: Series B
Raised Amount: $12.00M
Raised Date: 2014-01-01